Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05558527 · ClinicalTrials.gov registry record · NA
The Social Regulation of Threat-related Vigilance and Arousal
A NA study, sponsored by University of Nevada, Reno.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT05558527: Recruiting NA study, sponsored by University of Nevada, Reno.
NCT05558527 is a NA study that is actively recruiting participants, run by University of Nevada, Reno. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05558527, a NA study, is actively recruiting participants, sponsored by University of Nevada, Reno.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study will examine the effects of social support on threat vigilance and arousal using eye tracking. We will also test the moderating effects of trauma and discrimination history.
Primary Outcome
Participants will view 15 pictures of natural environmental scenes for 10 seconds per image. We will use an eye tracker to examine the number of eye fixations per scene. A greater number of fixations during the 10 second presentation of a scene would indicate greater vigilance.
Interventions
- BEHAVIORAL social support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2025-12-18 |
| Est. Completion | 2029-12 |
| Phase | NA |
What NCT05558527 shows while recruiting
NCT05558527 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which social support is the first listed.
NCT05558527 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05558527 about?
NCT05558527 is a clinical study titled "The Social Regulation of Threat-related Vigilance and Arousal". This study will examine the effects of social support on threat vigilance and arousal using eye tracking. We will also test the moderating effects of trauma and discrimination history.
What is the current status of trial NCT05558527?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2025-12-18. Estimated completion is 2029-12.
What interventions are being tested in trial NCT05558527?
The interventions under investigation include: social support (BEHAVIORAL).
Who is sponsoring clinical trial NCT05558527?
This trial is sponsored by University of Nevada, Reno, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05558527's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI